These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 402497)
1. [Cross-resistance of tubercle bacilli (a review). (I) (author's transl)]. Tsukamura M Kekkaku; 1977 Jan; 52(1):17-20. PubMed ID: 402497 [No Abstract] [Full Text] [Related]
2. [Cross-resistance of tubercle bacilli. (A review II) (author's transl)]. Tsukamura M Kekkaku; 1977 Feb; 52(2):47-9. PubMed ID: 404456 [No Abstract] [Full Text] [Related]
3. [The degree of cross-resistance to kanamycin (KM) of tubercle bacilli resistant to capreomycin (CPM), and the degree of cross-resistance to KM and CPM of tubercle bacilli resistant to viomycin (VM) (author's transl)]. Inagake H; Yamadori H; Inoue N; Mabuchi H; Ikeda N; Maekawa N Kekkaku; 1980 Jul; 55(7):323-30. PubMed ID: 6162994 [No Abstract] [Full Text] [Related]
4. [Cross resistance of tubercle bacilli to KM, VM, CPM, LVM and TUM. I. The sensitivity of human tubercle bacilli isolated from patients to the five antibiotics (author's transl)]. Saito T; Fukuhara Y Kekkaku; 1974 Mar; 49(3):57-61. PubMed ID: 4136031 [No Abstract] [Full Text] [Related]
5. [The mutual cross-resistance of aminoglucoside and polypeptide antibiotics on tubercle bacilli (author's transl)]. Inagake H Kekkaku; 1980 Jun; 55(6):281-8. PubMed ID: 6774157 [No Abstract] [Full Text] [Related]
6. [Cross resistance of tubercle bacilli to KM, VM, CPM, LVM, and TUM. II. The susceptibility of antibiotic-resistant strains which were obtained in vitro to the five antibiotics (author's transl)]. Saito T; Fukuhara Y Kekkaku; 1974 Apr; 49(4):91-6. PubMed ID: 4137393 [No Abstract] [Full Text] [Related]
7. [Bactericidal effect of rifampicin on resting tubercle bacilli in vitro (author's transl)]. Kanai K; Kondo E Kekkaku; 1979 Feb; 54(2):89-92. PubMed ID: 108446 [No Abstract] [Full Text] [Related]
8. [The clinical significance of the critical drug concentration of rifampicin. Report 1. Studies on the MIC of rifampicin to tubercle bacilli isolated from the rifampicin untreated patients using 1% Ogawa medium (author's transl)]. Baba H; Azuma Y Kekkaku; 1976 Jan; 51(1):1-5. PubMed ID: 815708 [No Abstract] [Full Text] [Related]
9. [On the sensitivity to TUM-N of tubercle bacilli isolated from tuberculous patients who had never employed TUM-N--for determination of the critical concentration of TUM-N resistance (author's transl)]. Toyoara M Kekkaku; 1973 Sep; 48(9):405-10. PubMed ID: 4203986 [No Abstract] [Full Text] [Related]
10. [A study on the tubercle bacillus drug-resistance test for RFP, EB, 1321 Th and KM (author's transl)]. Xiao XL Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1981 Aug; 4(4):224-5. PubMed ID: 6804194 [No Abstract] [Full Text] [Related]
11. [Peracetic acid as a disinfectant in the fight against tuberculosis--experimental data-- (author's transl)]. Sachse H Z Erkr Atmungsorgane; 1976; 144(1):33-8. PubMed ID: 823717 [TBL] [Abstract][Full Text] [Related]
12. [Studies on thiacetazone resistance of tubercle bacilli. 3. Cross resistance between thiacetazone and ethionamide]. Osato T; Tsukagoshi K; Shimizu H Kekkaku; 1971 Apr; 46(4):89-92. PubMed ID: 4102105 [No Abstract] [Full Text] [Related]
13. [Studies on thiacetazone resistance of tubercle bacilli. I. Thiacetazone sensitivity of tubercle bacilli isolated from previously untreated tuberculous children]. Osato T; Tsukagoshi K; Shimizu H Kekkaku; 1971 May; 46(3):65-70. PubMed ID: 4101569 [No Abstract] [Full Text] [Related]
14. [Niacin test for differentiation of mycobacterium tuberculosis var. hominis from other acid-fast bacilli. IX. Niacin test on human tubercle bacilli rendered resistant to multiple drugs in vitro]. Ogawa T Kekkaku; 1967 May; 42(5):187-91. PubMed ID: 4964921 [No Abstract] [Full Text] [Related]
15. [A new medium for tubercle bacilli culture- 1% hemolyzed blood semiliquid medium (author's transl)]. Zheng YZ Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1980 Mar; 3(1):21-5. PubMed ID: 6775915 [No Abstract] [Full Text] [Related]
16. Studies on cross-resistance between isoniazid, isoxyl, teebazone, ethionamide and ethambutol of tubercle bacilli from patients never treated with those drugs except with isoniazid. Tan TH; The KS; Yang SY; Tan LS; Ko HL; Tjie HB; Chatim A Paediatr Indones; 1966; 6(1):32-8. PubMed ID: 4959380 [No Abstract] [Full Text] [Related]
17. Tubercle bacilli resistance to cycloserine. Zierski M; Rózewska M; Woźniak S Scand J Respir Dis Suppl; 1970; 71():291-5. PubMed ID: 4989519 [No Abstract] [Full Text] [Related]
18. [On the stability of Th-1314-resistance in tubercle bacilli in patients with pulmonary tuberculosis]. TSUKAMURA S Kekkaku; 1963 Apr; 38():172-5. PubMed ID: 13994586 [No Abstract] [Full Text] [Related]
19. [Phagocytosis of tubercle bacilli by macrophages. II. The growth of human type of tubercle bacilli H37Rv in macrophages from normal and vaccinated guinea pigs (author's transl)]. Zeng LC Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1982 Feb; 5(1):23-5. PubMed ID: 6807660 [No Abstract] [Full Text] [Related]
20. [Studies on the infection of drug-resistant tubercle bacilli. 3. Experimental studies on the infection of INH highly-resistant tubercle bacilli]. Osato T; Toyohara M; Aoki M; Hatori H Kekkaku; 1968 Nov; 43(11):473-9. PubMed ID: 4975533 [No Abstract] [Full Text] [Related] [Next] [New Search]